These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 11062136)
1. Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages. Barr FE; Pedigo H; Johnson TR; Shepherd VL Am J Respir Cell Mol Biol; 2000 Nov; 23(5):586-92. PubMed ID: 11062136 [TBL] [Abstract][Full Text] [Related]
2. Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection. Arnold R; König B; Galatti H; Werchau H; König W Immunology; 1995 Jul; 85(3):364-72. PubMed ID: 7558123 [TBL] [Abstract][Full Text] [Related]
3. Synergistically upregulated interleukin-10 production in cocultures of monocytes and T cells after stimulation with respiratory syncytial virus. Kauth M; Grage-Griebenow E; Rohde G; Anhenn O; Wiethege A; Schultze-Werninghaus G; Bufe A Int Arch Allergy Immunol; 2007; 142(2):116-26. PubMed ID: 17057409 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of IL-6 and TNF-alpha production by respiratory syncytial virus-infected macrophages in the neonate. Matsuda K; Tsutsumi H; Sone S; Yoto Y; Oya K; Okamoto Y; Ogra PL; Chiba S J Med Virol; 1996 Feb; 48(2):199-203. PubMed ID: 8835355 [TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. Panuska JR; Merolla R; Rebert NA; Hoffmann SP; Tsivitse P; Cirino NM; Silverman RH; Rankin JA J Clin Invest; 1995 Nov; 96(5):2445-53. PubMed ID: 7593633 [TBL] [Abstract][Full Text] [Related]
7. Effect of preexposure to ultrafine carbon black on respiratory syncytial virus infection in mice. Lambert AL; Trasti FS; Mangum JB; Everitt JI Toxicol Sci; 2003 Apr; 72(2):331-8. PubMed ID: 12660365 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Arnold R; Humbert B; Werchau H; Gallati H; König W Immunology; 1994 May; 82(1):126-33. PubMed ID: 7519169 [TBL] [Abstract][Full Text] [Related]
9. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages. Benne CA; Benaissa-Trouw B; van Strijp JA; Kraaijeveld CA; van Iwaarden JF Eur J Immunol; 1997 Apr; 27(4):886-90. PubMed ID: 9130640 [TBL] [Abstract][Full Text] [Related]
10. Ozone effect on respiratory syncytial virus infectivity and cytokine production by human alveolar macrophages. Soukup J; Koren HS; Becker S Environ Res; 1993 Feb; 60(2):178-86. PubMed ID: 8472647 [TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages. Midulla F; Huang YT; Gilbert IA; Cirino NM; McFadden ER; Panuska JR Am Rev Respir Dis; 1989 Sep; 140(3):771-7. PubMed ID: 2476959 [TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression. Tsutsumi H; Takeuchi R; Ohsaki M; Seki K; Chiba S J Leukoc Biol; 1999 Jul; 66(1):99-104. PubMed ID: 10410996 [TBL] [Abstract][Full Text] [Related]
14. Surfactant protein A down-regulates proinflammatory cytokine production evoked by Candida albicans in human alveolar macrophages and monocytes. Rosseau S; Hammerl P; Maus U; Günther A; Seeger W; Grimminger F; Lohmeyer J J Immunol; 1999 Oct; 163(8):4495-502. PubMed ID: 10510392 [TBL] [Abstract][Full Text] [Related]
15. Interaction between respiratory syncytial virus and particulate matter in guinea pig alveolar macrophages. Kaan PM; Hegele RG Am J Respir Cell Mol Biol; 2003 Jun; 28(6):697-704. PubMed ID: 12760967 [TBL] [Abstract][Full Text] [Related]
16. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. Becker S; Quay J; Soukup J J Immunol; 1991 Dec; 147(12):4307-12. PubMed ID: 1753101 [TBL] [Abstract][Full Text] [Related]
17. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro. Franke-Ullmann G; Pförtner C; Walter P; Steinmüller C; Lohmann-Matthes ML; Kobzik L; Freihorst J J Immunol; 1995 Jan; 154(1):268-80. PubMed ID: 7995946 [TBL] [Abstract][Full Text] [Related]
18. The role of TNF-alpha in eosinophilic inflammation associated with RSV bronchiolitis. Choi J; Callaway Z; Kim HB; Fujisawa T; Kim CK Pediatr Allergy Immunol; 2010 May; 21(3):474-9. PubMed ID: 20088864 [TBL] [Abstract][Full Text] [Related]
19. Cytokine amplification by respiratory syncytial virus infection in human nasal epithelial cells. Das S; Palmer OP; Leight WD; Surowitz JB; Pickles RJ; Randell SH; Buchman CA Laryngoscope; 2005 May; 115(5):764-8. PubMed ID: 15867636 [TBL] [Abstract][Full Text] [Related]
20. Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. Sano H; Nagai K; Tsutsumi H; Kuroki Y Eur J Immunol; 2003 Oct; 33(10):2894-902. PubMed ID: 14515273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]